Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Fluorouracil (5-FU)

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCHN1575

    01/08/2016

    A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care Therapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)


    Print this page for your doctor